Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XAEENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAENUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.467ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.467ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.467ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.467NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.484ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.484ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.484ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.484NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.476ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.476ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.476ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.476NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.19ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
A.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.19NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.18ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.18NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.404ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.404ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.404ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.404NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CV.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CV.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CV.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CV.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DJ.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DJ.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DJ.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DJ.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.73ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.73ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.73ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.73NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DW.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DW.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DW.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BR.5.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BR.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BR.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BR.5.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.75.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.75.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.75.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used